{"DataElement":{"publicId":"4151645","version":"1","preferredName":"Person Malignant Neoplasm Recurrent Disease Disease Progression Diagnosis Malignant Neoplasm Recurrent Disease Documented Type","preferredDefinition":"information related to the diagnosis of the return of signs and symptoms of cancer after a period of improvement based on the doumented return of a tumor.","longName":"2236731v1.0:3178332v1.0_Mali_R","context":"NRG","contextVersion":"1","DataElementConcept":{"publicId":"3178334","version":"1","preferredName":"Person Malignant Neoplasm Recurrent Disease Disease Progression Diagnosis","preferredDefinition":"information related to the diagnosis of the return of signs and symptoms of cancer after a period of improvement.","longName":"2236731v1.0:3178332v1.0","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2236731","version":"1","preferredName":"Person","preferredDefinition":"A human being.","longName":"C25190","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Person","conceptCode":"C25190","definition":"A human being.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9FC6DF7-66EB-4CAB-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-20","endDate":null,"createdBy":"UMLLOADER_MAGE","dateCreated":"2005-06-20","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3178332","version":"1","preferredName":"Malignant Neoplasm Recurrent Disease Disease Progression Diagnosis","preferredDefinition":"A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.  Malignant neoplasms usually metastasize to distant anatomic sites and may recur after excision.  The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin's and non-Hodgkin's lymphomas, leukemias, melanomas, and sarcomas. -- 2004:the return of a sign, symptom, or disease after a remission.:Cancer that continues to grow or spread.:The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","longName":"C9305:C38155:C17747:C15220","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Recurrent Disease","conceptCode":"C38155","definition":"The return of a disease after a period of remission.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Disease Progression","conceptCode":"C17747","definition":"A process that manifests as the worsening of a disease over time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Diagnosis","conceptCode":"C15220","definition":"The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"98673C70-BCC7-F305-E040-BB89AD436381","latestVersionIndicator":"Yes","beginDate":"2010-12-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2010-12-27","modifiedBy":"ONEDATA","dateModified":"2010-12-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"98673C70-BCD8-F305-E040-BB89AD436381","latestVersionIndicator":"Yes","beginDate":"2010-12-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2010-12-27","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"4151585","version":"1","preferredName":"Malignant Neoplasm Recurrent Disease Documented Type","preferredDefinition":"information relating to the doumented return of a tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.","longName":"Mali_Recu_Docu_Type","context":"NRG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Measurable disease","valueDescription":"Measurable_Disease","ValueMeaning":{"publicId":"3192381","version":"1","preferredName":"Measurable_Disease","longName":"3192381","preferredDefinition":"A tumor that can be accurately measured in size. This information can be used to judge response to treatment.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Measurable Disease","conceptCode":"C8507","definition":"A finding indicating that a subject has one or more measurable pathological lesions.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9C6D87AC-3AB1-D773-E040-BB89AD43475F","latestVersionIndicator":"Yes","beginDate":"2011-02-16","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-02-16","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F2381D0F-C725-F453-E040-BB89AD4318DE","beginDate":"2014-02-12","endDate":null,"createdBy":"REBOYJ","dateCreated":"2014-02-12","modifiedBy":"ONEDATA","dateModified":"2014-02-12","deletedIndicator":"No"},{"value":"Detectable (non-measurable disease)","valueDescription":"Detectable","ValueMeaning":{"publicId":"3192380","version":"1","preferredName":"Detectable","longName":"3192380","preferredDefinition":"A malignant neoplasm that is detectable but not measurable.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9C6D87AC-3A8E-D773-E040-BB89AD43475F","latestVersionIndicator":"Yes","beginDate":"2011-02-16","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-02-16","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F2381D0F-C73A-F453-E040-BB89AD4318DE","beginDate":"2014-02-12","endDate":null,"createdBy":"REBOYJ","dateCreated":"2014-02-12","modifiedBy":"ONEDATA","dateModified":"2014-02-12","deletedIndicator":"No"},{"value":"Biochemical recurrence","valueDescription":"Biochemical Recurrent Malignant Neoplasm","ValueMeaning":{"publicId":"3830574","version":"1","preferredName":"Biochemical Recurrent Malignant Neoplasm","longName":"3830574","preferredDefinition":"Of or relating to biochemistry; involving chemical processes in living organisms.: The reemergence of a malignant neoplasm after a period of remission. -- 2003","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Biochemical","conceptCode":"C25434","definition":"Of or relating to biochemistry; involving chemical processes in living organisms.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Recurrent Malignant Neoplasm","conceptCode":"C4813","definition":"The reemergence of a malignant neoplasm after a period of remission.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E2BF0702-CFF5-0F98-E040-BB89AD434CDA","latestVersionIndicator":"Yes","beginDate":"2013-07-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-07-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F2381D0F-C745-F453-E040-BB89AD4318DE","beginDate":"2014-02-12","endDate":null,"createdBy":"REBOYJ","dateCreated":"2014-02-12","modifiedBy":"ONEDATA","dateModified":"2014-02-12","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"4151584","version":"1","preferredName":"Malignant Neoplasm Recurrent Disease Documented Type","preferredDefinition":"A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.:The return of a disease after a period of remission.:Furnished with or supported by documents and documentation.:Something distinguishable as an identifiable class based on common qualities.","longName":"C9305:C38155:C25356:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Recurrent Disease","conceptCode":"C38155","definition":"The return of a disease after a period of remission.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Documented","conceptCode":"C25356","definition":"Furnished with or supported by documents and documentation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F2381D0F-C6F7-F453-E040-BB89AD4318DE","latestVersionIndicator":"Yes","beginDate":"2014-02-12","endDate":null,"createdBy":"REBOYJ","dateCreated":"2014-02-12","modifiedBy":"ONEDATA","dateModified":"2014-02-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F2381D0F-C708-F453-E040-BB89AD4318DE","latestVersionIndicator":"Yes","beginDate":"2014-02-12","endDate":null,"createdBy":"REBOYJ","dateCreated":"2014-02-12","modifiedBy":"REBOYJ","dateModified":"2014-03-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"2236731v1.0:3178332v1.0_Mali_R","type":"USED_BY","context":"NRG"}],"ReferenceDocuments":[{"name":"How was the recurrence docume","type":"Preferred Question Text","description":"How was the recurrence documented?","url":null,"context":"NRG"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F2381D0F-C750-F453-E040-BB89AD4318DE","latestVersionIndicator":"Yes","beginDate":"2014-02-12","endDate":null,"createdBy":"REBOYJ","dateCreated":"2014-02-12","modifiedBy":"FORMBUILDER","dateModified":"2014-09-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}